Therapeutic antibodies against ROR-1 protein and methods for use of same
US12222355B2 · kind B2 · utility
0Cited by
196References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 2022 |
| Grant date | Feb 11, 2025 |
| Priority date | — |
| Expiry date | Jul 31, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutic antibodies having binding specificity for ROR-1 expressed on cancer cells (particularly leukemic and lymphomic cells) and pharmaceutical compositions containing one or more such antibodies for use in treating cancer. Methods for diagnosing such cancers through in vitro detection of binding to ROR-1 protein expressed on putative cancer cells are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.